Medtronic Stock News

MiniMed Group, Inc., a Medtronic subsidiary, is targeting an IPO to fund growth and working capital amid diabetes device market expansion. MMED is well-positioned in automated insulin delivery, boasting an integrated product stack, strong recurring revenue, and international reach. Financials show rising revenue and gross profit, but operating leverage remains limited due to high R&D and pendin...

Brookfield Renewable aims to increase its dividend by 5% to 9% each year. Realty Income has hiked its dividend for 113 consecutive quarters.

Medtronic plc exemplifies a 'wonderful company at a fair price,' trading near its calculated DCF fair value of $98 per share. MDT demonstrates nearly three decades of resilient revenue growth, high margins, and robust shareholder yield, underscoring its defensive investment appeal. The company boasts a 49-year dividend growth streak and has returned 42.2% of market cap to shareholders via buyba...

Medtronic will own at least 80.1% of the voting stock for MiniMed once the IPO is complete.

GALWAY, Ireland , Dec. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Diabetes business, which as previously announced will operate under the name MiniMed, has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) for a proposed initial public offering (IPO) of newly issued common...

MiniMed Group, the diabetes business of medical device maker Medtronic , filed for an initial public offering in the United States on Friday.

In October, we (my wife and I) received a dividend income total of $3,948.78. Crushing it for an off-month – thanks to Vanguard (VOO) and Fidelity (FXAIX) for paying in October. We had quite a few dividend increases this month. So fortunate to be getting raises from companies and having the stocks of companies I own do all of the work. In total, dividend increases created $92.48 in additional p...

Medtronic earned regulatory clearance in the U.S. for its Hugo robotic-assisted surgery system. This device will take time to have a material impact on the company's financial results.